A Phase I/II Clinical Study of Allogeneic Human Dermal Fibroblasts for Remodeling Scar Contractures
Latest Information Update: 24 Aug 2020
At a glance
- Drugs ICX-RHY (Primary)
- Indications Hypertrophic scars
- Focus Adverse reactions
Most Recent Events
- 02 Dec 2014 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov record.
- 27 Mar 2014 New trial record